alan venook, md, provides opinions of the opra data in rectal cancer patients presented at asco20

Published 4 years ago • 121 plays • Length 2:59

Download video MP4
Download video MP3

Similar videos

9:22

debate 5: is there a role for adjuvant oxaliplatin in rectal cancer? - no
2:12

alan venook, md, considers how i-o is evolving towards the first line treatment of colorectal cancer
0:37

trials to watch in rectal cancer
1:33

alan venook, md, outlines the role of liquid biopsy in gastrointestinal cancers
1:05

alan p. venook, md, on integrating immunotherapy into treatment regimens for gastric cancer patients
1:12

the future role of organ preservation in rectal cancer
1:39

alan venook, md, discusses next generation sequencing and mcrc treatment
0:48

dr. venook discusses the future of colorectal cancer treatment
47:46

online seminar - intra-tumor heterogeneity in glioma
8:24

hrqol, diagnosis and treatment experiences of patients with al amyloidosis: a survey by mpe
1:23:25

harnessing innovation in bladder cancer care
1:13

alan venook, md, on the impact of dose escalation of regorafenib in mcrc patients
7:31

debate 5: is there a role for adjuvant oxaliplatin in rectal cancer? - yes
1:23

dr. venook on immunotherapy potential in colorectal cancer
2:16

alan venook, md, describes the potential practice changing results of the keynote-177 study
15:17

organ preservation in rectal cancer: how and for whom?
2:05

challenges associated with organ preservation in patients with rectal cancer
1:26

alan venook, md, provides thoughts on the clinical progress of trastuzumab-deruxtecan in gi cancers
2:03

alan venook, md, explains the biological difference between left-sided and right-sided crc tumors
2:39

journal club - locally advanced rectal cancer highly sensitive to single-agent pd-1 blockade
2:16

alan venook, md, on potential new standard in care post approval of atezolizumab bevacizumab
1:30

alan venook, md, discusses vemurafenib and the nccn guidelines for mcrc patients

Clip.africa.com - Privacy-policy